Retrieve available abstracts of 45 articles: HTML format
Single Articles
May 2025
LU X, Zhu X, Li G, Wu L, et al Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the
Risk of Cardiometabolic Multimorbidity.
J Clin Endocrinol Metab. 2025;110:e1845-e1855. PubMedAbstract available
POHLMAN N, Patel PN, Essien UR, Tang JJ, et al Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome
Era.
J Clin Endocrinol Metab. 2025 May 19:dgaf295. doi: 10.1210. PubMedAbstract available
April 2025
BJORNSDOTTIR S, Mannstadt M, Clarke B, Spelman T, et al Increased risk of cardiovascular diseases in patients with chronic
hypoparathyroidism in Sweden.
J Clin Endocrinol Metab. 2025 Apr 28:dgaf257. doi: 10.1210. PubMedAbstract available
HOLLEY M, Razvi S, Maxwell I, Dew R, et al Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United
Kingdom population (ACEL-UK): Cohort Study.
J Clin Endocrinol Metab. 2025 Apr 3:dgaf208. doi: 10.1210. PubMedAbstract available
TELES BSBS, Ramalho SHR, Bittencourt MS, Bensenor IM, et al Plasma levels of small HDL particles are associated with coronary atherosclerosis
progression in adults with diabetes.
J Clin Endocrinol Metab. 2025 Apr 3:dgaf215. doi: 10.1210. PubMedAbstract available
March 2025
BENE-ALHASAN Y, Shitole SG, Buzkova P, Hirsch CH, et al Non-Esterified Fatty Acid Profiles and Cause-Specific Mortality: The
Cardiovascular Health Study.
J Clin Endocrinol Metab. 2025 Mar 24:dgaf182. doi: 10.1210. PubMedAbstract available
MITA T, Osonoi Y, Someya Y, Osonoi T, et al Relationship of carbohydrate intake proportion to cardiovascular events in
Japanese people with type 2 diabetes mellitus.
J Clin Endocrinol Metab. 2025 Mar 21:dgaf179. doi: 10.1210. PubMedAbstract available
SONAWALLA A, Chasman DI, Chan YM Age at Menarche and Coronary Artery Disease Risk: Divergent Associations with
Different Sources of Variation.
J Clin Endocrinol Metab. 2025 Mar 10:dgaf141. doi: 10.1210. PubMedAbstract available
NISHIO Y Does Insulin Work as Good One or Bad One for the Cardiovascular Tissues?
J Clin Endocrinol Metab. 2025 Mar 7:dgaf051. doi: 10.1210. PubMed
February 2025
HSIAO YY, Chen YY, Kuo MJ, Chien YS, et al SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation
and Diabetes: A TriNetX Cohort Study.
J Clin Endocrinol Metab. 2025 Feb 25:dgae861. doi: 10.1210. PubMedAbstract available
Correction to: "Associations Between Subclinical Thyroid Dysfunction and
Cardiovascular Risk Factors According to Age and Sex".
J Clin Endocrinol Metab. 2025 Feb 11:dgaf061. doi: 10.1210. PubMed
JIANG L, Zhou L, Liu J, Wang Y, et al Sex Differences in the Association Between Thyroid Hormone Sensitivity and
Cardiovascular-Kidney-Metabolic Syndrome.
J Clin Endocrinol Metab. 2025 Feb 4:dgaf059. doi: 10.1210. PubMedAbstract available
January 2025
CHOE HJ, Choi YM, Ha Y, Kim J, et al The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk
Evaluation Among Euthyroid Koreans.
J Clin Endocrinol Metab. 2025 Jan 22:dgaf046. doi: 10.1210. PubMedAbstract available
AN J, Zhang S, Cheng X, Jia C, et al The Association between Serum Polychlorinated Biphenyls and Incident
Cardiovascular Disease among Type 2 Diabetes.
J Clin Endocrinol Metab. 2025 Jan 15:dgaf014. doi: 10.1210. PubMedAbstract available
WANG S, Zhang Y, Balati A, Li B, et al Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in
Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised
Controlled Trials.
J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210. PubMedAbstract available
December 2024
Correction to: "Cardiovascular Safety of Romosozumab vs PTH Analogues for
Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study".
J Clin Endocrinol Metab. 2024 Dec 17:dgae870. doi: 10.1210. PubMed
BARETELLA O, Blum MR, Abolhassani N, Alwan H, et al Associations between subclinical thyroid dysfunction and cardiovascular risk
factors according to age and sex.
J Clin Endocrinol Metab. 2024 Dec 12:dgae860. doi: 10.1210. PubMedAbstract available
AZIZI M, Riancho J, Amar L Aldosterone synthase inhibitors: a potential revival for treatment of renal and
cardiovascular diseases.
J Clin Endocrinol Metab. 2024 Dec 4:dgae823. doi: 10.1210. PubMedAbstract available
November 2024
SHI B, Liu Z, Zhang R, Tiemuerniyazi X, et al Subclinical hypothyroidism as an independent predictor of cardiovascular
prognosis in left ventricular thrombus patients.
J Clin Endocrinol Metab. 2024 Nov 11:dgae793. doi: 10.1210. PubMedAbstract available
September 2024
LEBLANC E, Brooks N, Davies M, Chatterjee R, et al Sex-specific Cardiovascular Risk Factors and Treatment in Females with T2DM and
CVD: Developments and Knowledge Gaps.
J Clin Endocrinol Metab. 2024 Sep 23:dgae655. doi: 10.1210. PubMedAbstract available
GEORGIOPOULOS G, Athanasopoulos S, Mavraganis G, Konstantaki C, et al Incremental value of blood-based markers of liver fibrosis in cardiovascular risk
stratification.
J Clin Endocrinol Metab. 2024 Sep 11:dgae619. doi: 10.1210. PubMedAbstract available
PAQUETTE M, Trinder M, Guay SP, Brunham LR, et al Predictors of cardiovascular disease in individuals with dysbetalipoproteinemia:
a prospective study in the UK Biobank.
J Clin Endocrinol Metab. 2024 Sep 7:dgae618. doi: 10.1210. PubMedAbstract available
August 2024
YANG C, Ji L, Han X Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated
with an increased risk of cardiovascular disease: a Meta-analysis.
J Clin Endocrinol Metab. 2024 Aug 30:dgae602. doi: 10.1210. PubMedAbstract available
CHENG W, Geng S, Li Y, Chen R, et al Sex Differences in 'Life's Essential 8' cardiovascular health and Type 2 Diabetes
Mellitus Risk Across Menopause Stages.
J Clin Endocrinol Metab. 2024 Aug 16:dgae557. doi: 10.1210. PubMedAbstract available
ABU IRSHEED G, Martyn-Nemeth P, Baron KG, Reutrakul S, et al Sleep disturbances in type 1 diabetes and mitigating cardiovascular risk.
J Clin Endocrinol Metab. 2024 Aug 6:dgae539. doi: 10.1210. PubMedAbstract available
July 2024
YOUNIS JS, Taylor HS Is there an Association between Endometriosis, Early Menopause, and
Cardiovascular Disease?
J Clin Endocrinol Metab. 2024 Jul 31:dgae508. doi: 10.1210. PubMedAbstract available
HEIANZA Y, Tiwari S, Wang X, Watrous JD, et al Gut-Microbiota-Related Metabolite Phenylacetylglutamine and Risk of Incident
Coronary Heart Disease among Women.
J Clin Endocrinol Metab. 2024 Jul 30:dgae525. doi: 10.1210. PubMedAbstract available
SONG DK, Oh J, Sung YA, Hong YS, et al All-cause mortality and incidence of cardiovascular diseases in lean patients
with newly diagnosed type 2 diabetes.
J Clin Endocrinol Metab. 2024 Jul 26:dgae449. doi: 10.1210. PubMedAbstract available
HENNEY AE, Gillespie CS, Lai JYM, Schofield P, et al Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with
polycystic ovary syndrome.
J Clin Endocrinol Metab. 2024 Jul 11:dgae481. doi: 10.1210. PubMed
June 2024
CHAROENSRI S, Auchus RJ Response to Letter to the Editor From Tang and Zhang: "Predictors of
Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital
Adrenal Hyperplasia".
J Clin Endocrinol Metab. 2024 Jun 26:dgae402. doi: 10.1210. PubMed
TANG C, Zhang S Letter to the Editor From Tang and Zhang: "Predictors of Cardiovascular
Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal
Hyperplasia".
J Clin Endocrinol Metab. 2024 Jun 26:dgae401. doi: 10.1210. PubMed
May 2024
STOKAR J, Szalat A Response to Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of
Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score
Matched Cohort Study.
J Clin Endocrinol Metab. 2024 May 20:dgae348. doi: 10.1210. PubMed
KAWAGUCHI H Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs.
PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study'.
J Clin Endocrinol Metab. 2024 May 18:dgae347. doi: 10.1210. PubMed
FARR JN Cardiovascular Safety and Romosozumab - The Plot Thickens.
J Clin Endocrinol Metab. 2024 May 8:dgae313. doi: 10.1210. PubMed
April 2024
KAJIKAWA M, Maruhashi T, Kishimoto S, Yamaji T, et al A Body Shape Index as a Simple Anthropometric Marker of Abdominal Obesity and
Risk of Cardiovascular Events.
J Clin Endocrinol Metab. 2024 Apr 25:dgae282. doi: 10.1210. PubMedAbstract available
ZHANG G, Jiang W, He F, Fu J, et al LDL-C and TC mediate the risk of PNPLA3 inhibition on cardiovascular diseases.
J Clin Endocrinol Metab. 2024 Apr 18:dgae264. doi: 10.1210. PubMedAbstract available
CHE J, He N, Kuang X, Zheng C, et al Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in
patients with pre-diabetes and diabetes.
J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210. PubMedAbstract available
SONG X, Xiong L, Guo T, Chen X, et al Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in
US Adults with Metabolic Syndrome.
J Clin Endocrinol Metab. 2024 Apr 10:dgae225. doi: 10.1210. PubMedAbstract available
March 2024
QIU Z, Lee DH, Lu Q, Li R, et al Associations of Regional Body Fat with Risk of Cardiovascular Disease and
Mortality among Individuals with Type 2 Diabetes.
J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210. PubMedAbstract available
VAN DER VALK ES, Mohseni M, Iyer AM, van den Hurk M, et al Long-term glucocorticoid exposure and incident cardiovascular diseases - the
Lifelines cohort.
J Clin Endocrinol Metab. 2024 Mar 19:dgae081. doi: 10.1210. PubMedAbstract available
STOKAR J, Szalat A Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment:
a Propensity Score Matched Cohort Study.
J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210. PubMedAbstract available
COSTA FC, Gomes LG, de Lima TM, Bortolotto LA, et al Cardiovascular risk in women with nonclassical congenital adrenal hyperplasia.
J Clin Endocrinol Metab. 2024 Mar 11:dgae155. doi: 10.1210. PubMedAbstract available
February 2024
CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease
in Type 2 Diabetes: A UK Biobank Study.
J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210. PubMedAbstract available
January 2024
PARK SY, Jun JE, Jeong IK, Ahn KJ, et al Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity
Statin Monotherapy in Type 2 Diabetes.
J Clin Endocrinol Metab. 2024 Jan 4:dgad714. doi: 10.1210. PubMedAbstract available
October 2023
HIRSCHBERG AL Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What
Is the Evidence?
J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210. PubMedAbstract available